Back

Anti-inflammatory secondary prevention: what’s next?

11 April 2019 (09:37 - 10:00)
Organised by:
Congress Presentation Part of: Targeting inflammation in atherosclerosis: burning questions Lipids EAPC Premium Access EuroPrevent 2019

About the speaker

Photo
Doctor Giuseppina Caligiuri

National Institute of Health and Medical Research (INSERM home), Paris (France)

3 More presentations in this session

Presentation thumbnail
Are there hidden powers in omega-3 fatty acids?
Professor M. Back (Stockholm, SE)
Video
Presentation thumbnail
Inflammation, exercise and atrial fibrillation
Doctor A. Elliott (Adelaide, AU)
Slides Video
Presentation thumbnail
Anti-inflammation, PCSK9 inhibition, or both?
Professor J. Tunon Fernandez (Madrid, ES)
Slides Video

Access the full session

Session thumbnail
Targeting inflammation in atherosclerosis: burning questions

The Event

Event poster

EuroPrevent 2019

11 April 2019 09:37 CET
You may be interested in
thumbnail
Webinar
Aspirin treatment for mitigating thrombotic risk across the cardiovascular risk continuum
6 July 2023
thumbnail
Congress Presentation
Including patient perspectives in secondary prevention: one step closer to patients needs
15 June 2024
thumbnail
Congress Session
Clonal hematopoiesis of indeterminate potential in cardiovascular disease: from atherosclerosis to heart failure
17 May 2025
thumbnail
Congress Presentation
Is there value in prescribing colchicine in coronary artery disease for secondary prevention: a meta-analysis of over 5,000 patients
28 August 2020

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources